abstract |
(57) Abstract The present invention is based on the discovery that the administration of at least one immunoconjugate and at least one chemotherapeutic agent results in unexpectedly superior treatment in treating cancer. The present invention relates to compositions comprising at least one immune complex and at least one chemotherapeutic agent, and methods of treating cancer using at least one immunoconjugate and at least one chemotherapeutic agent. . The invention further provides a method of modulating the growth of a selected cell population, such as a cancer cell, by administering a therapeutically effective amount of at least one chemotherapeutic agent and at least one immune complex. |